still not yet full of the production capacity to cover the fixed costs. 3. Selling expenses For Quarter 2 of the year 2019, the selling expenses was 3.46 million baht or 3.74% from sale revenue compare to

Quarter Change (%) H1 Change 2/2018 1/2018 2/2017 1/2018 2/2017 2018 2017 (%) Net profit * 9,194 9,005 8,047 2.1% 14.3% 18,199 16,352 11.3% Earnings per share (Baht) 4.82 4.72 4.22 2.1% 14.3% 9.53 8.57 11.3

Name Fund Type Fund Name Fund Abbr. Name Approval Date First Sell Start Date First Sell End Date Remark Filing (Thai version only)   Mutual Fund SCB Foreign Fixed Income Fund 6MP8 Not for Retail

128,745 Change 92,046 32,320 7,842 -13,460 364,758 % Change 11.0 11.0 9.8 (14.4) 154.5 In overall, the Company and its subsidiaries had the net profit in the year 2018 at 128.7 MB increased 364.8 MB by

which came from additional investments in investments in associated companies and fixed assets. Net cash from financing activities was Baht 1,496.09 million mainly from increased short-term debt. As a

stated ) Q1 2017 Q1 2016 Change Amount % Total Revenues 3,946 3,910 36 0.9% Sales and service income 3,829 3,818 8 0.2% Other income 117 92 25 27.9% Cost of sales and services 3,533 3,550 (17) -0.5% SG&A

as highlighted below ; (Unit : Million Baht) Separate financial statements 2017 2016 % Change Sales and Service Income 1,979.16 1,986.34 -0.36 Cost of sales and Services 1,525.25 1,449.23 +5.25 Selling

in Q2/2017. (Unit: Thousand Baht) Revenues Gross Profit Selling Admin Net(loss) profit Q2/17 222,225 80,232 19,957 22,698 (293,091)*** Q2/18 221,202 78,238 21,637 19,916 35,335 Change -1,023 -1,994

margin was higher as the company could be Revenues Gross Profit Selling Admin Net profit 3Q/17 185,920 62,255 17,599 18,053 19,079 3Q/18 249,407 89,092 21,509 18,502 32,736 Change 63,487 26,837 3,910 449

follows: Unit: Million Baht Revenue Structure Q3/2019 Q3/2018 Change General Patient Revenue 1,683.8 1,518.9 164.9 10.9% Social Security Scheme Revenue 785.4 709.1 76.3 10.8% Other Revenue 31.3 26.3 5.0